Page last updated: 2024-09-03

20-hydroxy-5,8,11,14-eicosatetraenoic acid and Polycystic Kidney, Autosomal Recessive

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Polycystic Kidney, Autosomal Recessive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akbulut, T; Avner, ED; Birudaraju, S; Falck, JR; Jia, G; Mueller, B; Park, F; Roman, RJ; Sweeney, WE1

Other Studies

1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Polycystic Kidney, Autosomal Recessive

ArticleYear
Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD.
    American journal of physiology. Renal physiology, 2009, Volume: 296, Issue:3

    Topics: 8,11,14-Eicosatrienoic Acid; Amidines; Animals; Cyclic AMP; Cytochrome P-450 CYP4A; Disease Models, Animal; Enzyme Activation; Epoxy Compounds; Extracellular Signal-Regulated MAP Kinases; Hydroxyeicosatetraenoic Acids; Kidney; Male; Microsomes; Organ Size; Polycystic Kidney, Autosomal Recessive; Protein Isoforms; Rats; Rats, Sprague-Dawley; RNA, Messenger

2009